KITE

Kite Pharma, Inc.

KITE

Delisted

KITE was delisted on the 2nd of October, 2017.

244 hedge funds and large institutions have $8.87B invested in Kite Pharma, Inc. in 2017 Q3 according to their latest regulatory filings, with 105 funds opening new positions, 52 increasing their positions, 67 reducing their positions, and 80 closing their positions.

2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2

Holders

244

Holders Change

+24

Holders Change %

+10.91%

% of All Funds

6.09%

Holding in Top 10

Holding in Top 10 Change

+13

Holding in Top 10 Change %

+130%

% of All Funds

0.57%

New

105

Increased

Reduced

Closed

Calls

$451M

Puts

$628M

Net Calls

-$176M

Net Calls Change

-$261M

Top Buyers

1	CI 1 Cowen Inc New York	$755M
2	2 Fidelity Investments Boston, Massachusetts	$278M
3	TCSAM 3 Tyrus Capital S.A.M. Monaco	$236M
4	FCM 4 Farallon Capital Management San Francisco, California	$175M
5	5 Renaissance Technologies New York	$140M

Top Sellers

1	1 Capital Research Global Investors Los Angeles, California	$0
2	2 T. Rowe Price Associates Baltimore, Maryland	$483M
3	PHS 3 PFM Health Sciences San Francisco, California	$529K
4	4 Capital World Investors Los Angeles, California	$202M
5	5 Capital International Investors Los Angeles, California	$35.7M

#	Name	Market Value	Shares	Shares Change	Shares Change %
1	CI 1 Cowen Inc New York	$755M	4,200,600	+4,200,600	New
2	2 BlackRock New York	$744M	4,137,189	+141,917	+4%
3	3 Vanguard Group Malvern, Pennsylvania	$736M	4,094,002	+95,733	+2%
4	4 T. Rowe Price Associates Baltimore, Maryland	$483M	2,683,954	-2,431,685	-48%
5	WCM 5 Wildcat Capital Management New York	$433M	2,410,034	–	–
6	6 Fidelity Investments Boston, Massachusetts	$278M	1,548,000	+1,412,702	+1,044%
7	7 JPMorgan Chase & Co New York	$275M	1,528,805	-838,947	-35%
8	8 State Street Boston, Massachusetts	$248M	1,377,399	-347,168	-20%
9	TCSAM 9 Tyrus Capital S.A.M. Monaco	$236M	1,314,812	+1,314,812	New
10	10 Capital World Investors Los Angeles, California	$202M	1,122,400	-1,448,000	-56%
11	FCM 11 Farallon Capital Management San Francisco, California	$175M	974,435	+974,435	New
12	WRF 12 Waddell & Reed Financial Overland Park, Kansas	$171M	950,600	-54,200	-5%
13	13 Goldman Sachs New York	$145M	806,480	+411,200	+104%
14	14 Royal Bank of Canada Toronto, Ontario, Canada	$144M	798,569	+43,500	+6%
15	15 Renaissance Technologies New York	$140M	778,300	+778,300	New
16	GLAM 16 Gardner Lewis Asset Management Chadds Ford, Pennsylvania	$139M	773,817	+773,817	New
17	AA 17 AQR Arbitrage Greenwich, Connecticut	$137M	759,314	+759,314	New
18	OP 18 Omni Partners London, United Kingdom	$119M	661,711	+661,711	New
19	19 Deutsche Bank Frankfurt Am Main Ge, Germany	$119M	659,115	+451,378	+217%
20	GF 20 Gabelli Funds Rye, New York	$112M	622,232	+622,232	New
21	21 Northern Trust Chicago, Illinois	$102M	568,557	-22,582	-4%
22	MF 22 Magnetar Financial Evanston, Illinois	$99.4M	552,659	+552,659	New
23	23 Adage Capital Partners Boston, Massachusetts	$98.9M	550,000	+550,000	New
24	ACA 24 Avoro Capital Advisors New York	$89.4M	496,983	-309,767	-38%
25	25 Morgan Stanley New York	$88M	489,605	+345,039	+239%

Kite Pharma, Inc. KITE

Top Buyers

Top Sellers

Kite Pharma, Inc.

KITE